{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:06:36Z","timestamp":1785207996646,"version":"3.55.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018895","name":"National Institute of Technology, Raipur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.compbiolchem.2026.109012","type":"journal-article","created":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T15:52:25Z","timestamp":1774194745000},"page":"109012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["In silico discovery of selective TPX2 and BUB1B inhibitors as novel antimitotic agents in breast cancer therapy"],"prefix":"10.1016","volume":"123","author":[{"given":"Bharath Kumar","family":"Jakkula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Perugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiolchem.2026.109012_bib1","doi-asserted-by":"crossref","unstructured":"S. Aggarwal, S.S. Verma, S. Aggarwal, and S.C. Gupta, \u201cDrug repurposing for breast cancer therapy: Old weapon for new battle,\u201d Jan. 01, 2021a, Academic Press. doi: 10.1016\/j.semcancer.2019.09.012.","DOI":"10.1016\/j.semcancer.2019.09.012"},{"key":"10.1016\/j.compbiolchem.2026.109012_bib2","doi-asserted-by":"crossref","unstructured":"S. Aggarwal, S.S. Verma, S. Aggarwal, and S.C. Gupta, \u201cDrug repurposing for breast cancer therapy: Old weapon for new battle,\u201d Jan. 01, 2021b, Academic Press. doi: 10.1016\/j.semcancer.2019.09.012.","DOI":"10.1016\/j.semcancer.2019.09.012"},{"key":"10.1016\/j.compbiolchem.2026.109012_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1598883","article-title":"Evaluating the multitargeted potency of Pixuvri against cell cycle regulation proteins in cervical cancer","volume":"15","author":"Alshehri","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.compbiolchem.2026.109012_bib4","doi-asserted-by":"crossref","unstructured":"M.R. Arkin, Y. Tang, and J.A. Wells, \u201cSmall-molecule inhibitors of protein-protein interactions: Progressing toward the reality,\u201d Sep. 18, 2014, Elsevier Ltd. doi: 10.1016\/j.chembiol.2014.09.001.","DOI":"10.1016\/j.chembiol.2014.09.001"},{"key":"10.1016\/j.compbiolchem.2026.109012_bib5","doi-asserted-by":"crossref","unstructured":"I.A. Asteriti et al., \u201cIdentification of small molecule inhibitors of the Aurora-A\/TPX2 complex,\u201d 2017. [Online]. Available: \u3008www.impactjournals.com\/oncotarget\u3009.","DOI":"10.18632\/oncotarget.16738"},{"key":"10.1016\/j.compbiolchem.2026.109012_bib6","doi-asserted-by":"crossref","unstructured":"B.J. Aungst, \u201cOptimizing Oral Bioavailability in Drug Discovery: An Overview of Design and Testing Strategies and Formulation Options,\u201d Apr. 01, 2017, Elsevier B.V. doi: 10.1016\/j.xphs.2016.12.002.","DOI":"10.1016\/j.xphs.2016.12.002"},{"key":"10.1016\/j.compbiolchem.2026.109012_bib7","doi-asserted-by":"crossref","unstructured":"R. Bayliss, S.G. Burgess, and P.J. McIntyre, \u201cSwitching Aurora-A kinase on and off at an allosteric site,\u201d Sep. 01, 2017, Blackwell Publishing Ltd. doi: 10.1111\/febs.14069.","DOI":"10.1111\/febs.14069"},{"issue":"15","key":"10.1016\/j.compbiolchem.2026.109012_bib8","doi-asserted-by":"crossref","first-page":"E3416","DOI":"10.1073\/pnas.1711490115","article-title":"Exploring the structural origins of cryptic sites on proteins","volume":"115","author":"Beglov","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.compbiolchem.2026.109012_bib9","article-title":"Kinase-targeted cancer therapies: progress, challenges and future directions","author":"Bhullar","year":"2018","journal-title":"BioMed. Cent. Ltd"},{"key":"10.1016\/j.compbiolchem.2026.109012_bib10","doi-asserted-by":"crossref","unstructured":"V.M. Bolanos-Garcia and T.L. Blundell, \u201cBUB1 and BUBR1: Multifaceted kinases of the cell cycle,\u201d Mar. 2011. doi: 10.1016\/j.tibs.2010.08.004.","DOI":"10.1016\/j.tibs.2010.08.004"},{"key":"10.1016\/j.compbiolchem.2026.109012_bib11","article-title":"Editorial: Opportunities and challenges in drug repurposing","author":"Camps","year":"2025","journal-title":"Front. Media SA"},{"key":"10.1016\/j.compbiolchem.2026.109012_bib12","doi-asserted-by":"crossref","unstructured":"I.P. de Castro and M. Malumbres, \u201cMitotic Stress and Chromosomal Instability in Cancer: The Case for TPX2,\u201d Nov. 01, 2012, SAGE Publications Inc. doi: 10.1177\/1947601912473306.","DOI":"10.1177\/1947601912473306"},{"issue":"5","key":"10.1016\/j.compbiolchem.2026.109012_bib13","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.compbiolchem.2026.109012_bib14","article-title":"Mechanism of CDK4\/6 inhibitor resistance in hormone receptor-positive breast cancer and alternative treatment strategies","author":"Chang","year":"2023","journal-title":"Int. Inst. Anticancer Res."},{"issue":"8","key":"10.1016\/j.compbiolchem.2026.109012_bib15","article-title":"HDAC-targeting epigenetic modulators for cancer immunotherapy","volume":"265","author":"Cheng","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2026.109012_bib16","doi-asserted-by":"crossref","unstructured":"F. Cheng, Q. Xu, Q. Li, Z. Cui, W. Li, and F. Zeng, \u201cAdverse reactions after treatment with dasatinib in chronic myeloid leukemia: Characteristics, potential mechanisms, and clinical management strategies,\u201d Feb. 06, 2023, Frontiers Media S.A. doi: 10.3389\/fonc.2023.1113462.","DOI":"10.3389\/fonc.2023.1113462"},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109012_bib17","doi-asserted-by":"crossref","DOI":"10.1007\/s44163-025-00224-w","article-title":"An improved soft voting-based machine learning technique to detect breast cancer utilizing effective feature selection and SMOTE-ENN class balancing","volume":"5","author":"Chhillar","year":"2025","journal-title":"Discov. Artif. Intell."},{"issue":"D1","key":"10.1016\/j.compbiolchem.2026.109012_bib18","doi-asserted-by":"crossref","first-page":"D138","DOI":"10.1093\/nar\/gkad965","article-title":"NCBI GEO: archive for gene expression and epigenomics data sets: 23-year update","volume":"52","author":"Clough","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.compbiolchem.2026.109012_bib19","doi-asserted-by":"crossref","unstructured":"B. Costa, I. Amorim, F. G\u00e4rtner, and N. Vale, \u201cUnderstanding Breast cancer: from conventional therapies to repurposed drugs,\u201d Aug. 01, 2020, Elsevier B.V. doi: 10.1016\/j.ejps.2020.105401.","DOI":"10.1016\/j.ejps.2020.105401"},{"issue":"12","key":"10.1016\/j.compbiolchem.2026.109012_bib20","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1016\/j.celrep.2019.05.004","article-title":"Two distinct E2F transcriptional modules drive cell cycles and differentiation","volume":"27","author":"Cuiti\u00f1o","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.compbiolchem.2026.109012_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2019.00695","article-title":"Identification of potential crucial genes and key pathways in breast cancer using bioinformatic analysis","volume":"10","author":"Deng","year":"2019","journal-title":"Front. Genet"},{"issue":"7","key":"10.1016\/j.compbiolchem.2026.109012_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-024-06914-0","article-title":"BUB1b impairs chemotherapy sensitivity via resistance to ferroptosis in lung adenocarcinoma","volume":"15","author":"Ding","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.compbiolchem.2026.109012_bib23","doi-asserted-by":"crossref","unstructured":"E.D. Eisenmann, Z. Talebi, A. Sparreboom, and S.D. Baker, \u201cBoosting the oral bioavailability of anticancer drugs through intentional drug-drug interactions,\u201d Jan. 01, 2022, John Wiley and Sons Inc. doi: 10.1111\/bcpt.13623.","DOI":"10.1111\/bcpt.13623"},{"key":"10.1016\/j.compbiolchem.2026.109012_bib24","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.procs.2024.10.302","article-title":"Comparative analysis of machine learning and survival analysis for breast cancer prediction","volume":"245","author":"Emily","year":"2024","journal-title":"Procedia Comput. Sci."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109012_bib25","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-022-04662-6","article-title":"Computationally repurposing drugs for breast cancer subtypes using a network-based approach","volume":"23","author":"Firoozbakht","year":"2022","journal-title":"BMC Bioinforma."},{"issue":"W1","key":"10.1016\/j.compbiolchem.2026.109012_bib26","doi-asserted-by":"crossref","first-page":"W422","DOI":"10.1093\/nar\/gkae236","article-title":"ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support","volume":"52","author":"Fu","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.compbiolchem.2026.109012_bib27","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41388-018-0470-2","article-title":"TPX2\/Aurora kinase A signaling as a potential therapeutic target in genomically unstable cancer cells","volume":"38","author":"van Gijn","year":"2019","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.compbiolchem.2026.109012_bib28","first-page":"286","article-title":"TPX2 as a prognostic indicator and potential therapeutic target in clear cell renal cell carcinoma","volume":"35","author":"Glaser","year":"2017","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109012_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030890","article-title":"Ashwagandha derived withanone targets TPX2-Aurora a complex: computational and experimental evidence to its anticancer activity","volume":"7","author":"Grover","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.compbiolchem.2026.109012_bib30","doi-asserted-by":"crossref","unstructured":"Y. Guan, G. Wang, D. Fails, P. Nagarajan, and Y. Ge, \u201cUnraveling cancer lineage drivers in squamous cell carcinomas,\u201d Feb. 01, 2020, Elsevier Inc. doi: 10.1016\/j.pharmthera.2019.107448.","DOI":"10.1016\/j.pharmthera.2019.107448"},{"issue":"6","key":"10.1016\/j.compbiolchem.2026.109012_bib31","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3109\/10799893.2015.1041645","article-title":"Abrogation of AuroraA-TPX2 by novel natural inhibitors: molecular dynamics-based mechanistic analysis","volume":"35","author":"Gupta","year":"2015","journal-title":"J. Recept. Signal Transduct."},{"key":"10.1016\/j.compbiolchem.2026.109012_bib32","doi-asserted-by":"crossref","unstructured":"B.D. Guth and G. Rast, \u201cDealing with hERG liabilities early: Diverse approaches to an important goal in drug development,\u201d Jan. 2010. doi: 10.1111\/j.1476-5381.2009.00265.x.","DOI":"10.1111\/j.1476-5381.2009.00265.x"},{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109012_bib33","article-title":"Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors","volume":"5","author":"Gy\u0151rffy","year":"2024","journal-title":"Innovation"},{"key":"10.1016\/j.compbiolchem.2026.109012_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2025.108533","article-title":"Integrating in vitro, network pharmacology, and molecular docking approaches to uncover the antidiabetic potential of Tylophora hirsuta","volume":"119","author":"Hadi","year":"2025","journal-title":"Comput. Biol. Chem."},{"issue":"5","key":"10.1016\/j.compbiolchem.2026.109012_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26052061","article-title":"A comprehensive analysis revealing BUB1B as a potential prognostic and immunological biomarker in lung adenocarcinoma","volume":"26","author":"Hao","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109012_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-22202-z","article-title":"Adaptive multi-omics integration framework for breast cancer survival analysis","volume":"15","author":"Hasanzadeh","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiolchem.2026.109012_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2025.108431","article-title":"Identification of potential therapeutic targets for stroke using data mining, network analysis, enrichment, and docking analysis","volume":"117","author":"Hatamipour","year":"2025","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.compbiolchem.2026.109012_bib38","doi-asserted-by":"crossref","unstructured":"S. Herr\u00e1iz-Gil, E. Nygren-Jim\u00e9nez, D.N. Acosta-Alonso, C. Le\u00f3n, and S. Guerrero-Aspizua, \u201cArtificial Intelligence-Based Methods for Drug Repurposing and Development in Cancer,\u201d Mar. 01, 2025, Multidisciplinary Digital Publishing Institute (MDPI). doi: 10.3390\/app15052798.","DOI":"10.3390\/app15052798"},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109012_bib39","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-025-01121-1","article-title":"miR-193b-3p suppresses lung cancer cell migration and invasion through PRNP targeting","volume":"32","author":"Ho","year":"2025","journal-title":"J. Biomed. Sci."},{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109012_bib40","doi-asserted-by":"crossref","DOI":"10.21037\/cco-23-151","article-title":"Identification of most representative hub-genes for diagnosis, prognosis, and therapies of hepatocellular carcinoma","volume":"13","author":"Hossen","year":"2024","journal-title":"Chin. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109012_bib41","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s40203-025-00436-z","article-title":"Overexpression of the TPX2 gene is associated with enhanced tumor malignancy in lung adenocarcinoma and identification of marine natural inhibitors of the Aurora kinase A-TPX2 protein complex","volume":"13","author":"Imtiaz","year":"2025","journal-title":"Silico Pharm."},{"key":"10.1016\/j.compbiolchem.2026.109012_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/srep28528","article-title":"Allosteric modulation of AURKA kinase activity by a small-molecule inhibitor of its protein-protein interaction with TPX2","volume":"6","author":"Jane\u010dek","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiolchem.2026.109012_bib43","doi-asserted-by":"crossref","unstructured":"W. Jiang, W. Ye, X. Tan, and Y.J. Bao, \u201cNetwork-based multi-omics integrative analysis methods in drug discovery: a systematic review,\u201d Dec. 01, 2025, BioMed Central Ltd. doi: 10.1186\/s13040-025-00442-z.","DOI":"10.1186\/s13040-025-00442-z"},{"key":"10.1016\/j.compbiolchem.2026.109012_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1569559","article-title":"Gene network centrality analysis identifies key regulators coordinating day-night metabolic transitions in Synechococcus elongatus PCC 7942 despite limited accuracy in predicting direct regulator-gene interactions","volume":"16","author":"Johnson","year":"2025","journal-title":"Front. Microbiol"},{"issue":"8","key":"10.1016\/j.compbiolchem.2026.109012_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e04642","article-title":"Virtual screening, molecular docking studies and DFT calculations of FDA approved compounds similar to the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz","volume":"6","author":"Jordaan","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.compbiolchem.2026.109012_bib46","doi-asserted-by":"crossref","unstructured":"E.D. Jurj, D. Colib\u0103\u0219anu, S.O. Vasii, L. Suciu, C.A. Dehelean, and L. Udrescu, \u201cRedefining Breast Cancer Care by Harnessing Computational Drug Repositioning,\u201d Sep. 01, 2025, Multidisciplinary Digital Publishing Institute (MDPI). doi: 10.3390\/medicina61091640.","DOI":"10.3390\/medicina61091640"},{"key":"10.1016\/j.compbiolchem.2026.109012_bib47","article-title":"A breast cancer-specific combinational QSAR model development using machine learning and deep learning approaches","volume":"3","author":"Karampuri","year":"2023","journal-title":"Front. Bioinforma."},{"key":"10.1016\/j.compbiolchem.2026.109012_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108433","article-title":"Exploratory drug discovery in breast cancer patients: a multimodal deep learning approach to identify novel drug candidates targeting RTK signaling","volume":"174","author":"Karampuri","year":"2024","journal-title":"Comput. Biol. Med."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109012_bib49","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-71076-0","article-title":"ResisenseNet hybrid neural network model for predicting drug sensitivity and repurposing in breast Cancer","volume":"14","author":"Karampuri","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiolchem.2026.109012_bib50","article-title":"EIOFX-DT: leveraging graph centrality metrics for feature extraction and classification of viral genetic sequences","volume":"49","author":"Khodaei","year":"2026","journal-title":"Biotechnol. Rep."},{"issue":"43","key":"10.1016\/j.compbiolchem.2026.109012_bib51","doi-asserted-by":"crossref","first-page":"6210","DOI":"10.1038\/s41388-021-02021-y","article-title":"Increased BUB1B\/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents","volume":"40","author":"Komura","year":"2021","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.compbiolchem.2026.109012_bib52","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10549-020-05962-2","article-title":"Spindle assembly checkpoint gene BUB1B is essential in breast cancer cell survival","volume":"185","author":"Koyuncu","year":"2021","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109012_bib53","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"10.1016\/j.compbiolchem.2026.109012_bib54","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/gutjnl-2016-313369","article-title":"Drug-induced liver injury: recent advances in diagnosis and risk assessment","volume":"66","author":"Kullak-Ublick","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.compbiolchem.2026.109012_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138435","article-title":"Quantification of total phenols in Coleus forskohlii and inhibition of aldose reductase by rosmarinic acid","volume":"1312","author":"Kundur","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.compbiolchem.2026.109012_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.929996","article-title":"Bioinformatics analysis reveals FOXM1\/BUB1B signaling pathway as a key target of neosetophomone B in human leukemic cells: a gene network-based microarray analysis","volume":"12","author":"Kuttikrishnan","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109012_bib57","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/cimb48010094","article-title":"Ensemble machine learning on bulk RNA-seq identifies 17-gene signature predicting neoadjuvant chemotherapy response in breast cancer","volume":"48","author":"Lamprou","year":"2026","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.compbiolchem.2026.109012_bib58","doi-asserted-by":"crossref","unstructured":"M. Layeghifard, D.M. Hwang, and D.S. Guttman, \u201cDisentangling Interactions in the Microbiome: A Network Perspective,\u201d Mar. 01, 2017, Elsevier Ltd. doi: 10.1016\/j.tim.2016.11.008.","DOI":"10.1016\/j.tim.2016.11.008"},{"issue":"10","key":"10.1016\/j.compbiolchem.2026.109012_bib59","article-title":"Excessive concentrations of kinase inhibitors in translational studies impede effective drug repurposing","volume":"4","author":"Liu","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"21","key":"10.1016\/j.compbiolchem.2026.109012_bib60","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1093\/bioinformatics\/bty411","article-title":"GSCALite: A web server for gene set cancer analysis","volume":"34","author":"Liu","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.compbiolchem.2026.109012_bib61","doi-asserted-by":"crossref","unstructured":"A. Llinas-Bertran, M. Butjosa-Esp\u00edn, V. Barberi, and J.A. Seoane, \u201cMultimodal data integration in early-stage breast cancer,\u201d Apr. 01, 2025, Churchill Livingstone. doi: 10.1016\/j.breast.2025.103892.","DOI":"10.1016\/j.breast.2025.103892"},{"key":"10.1016\/j.compbiolchem.2026.109012_bib62","doi-asserted-by":"crossref","unstructured":"Y. Ma, N. Shen, M.S. Wicha, and M. Luo, \u201cThe roles of the let-7 family of micrornas in the regulation of cancer stemness,\u201d Sep. 01, 2021, MDPI. doi: 10.3390\/cells10092415.","DOI":"10.3390\/cells10092415"},{"key":"10.1016\/j.compbiolchem.2026.109012_bib63","series-title":"Drugs repurposed: an advanced step towards the treatment of breast cancer and associated challenges","author":"Malik","year":"2022"},{"key":"10.1016\/j.compbiolchem.2026.109012_bib64","doi-asserted-by":"crossref","unstructured":"N. McGranahan, R.A. Burrell, D. Endesfelder, M.R. Novelli, and C. Swanton, \u201cCancer chromosomal instability: Therapeutic and diagnostic challenges,\u201d Jun. 2012. doi: 10.1038\/embor.2012.61.","DOI":"10.1038\/embor.2012.61"},{"issue":"7","key":"10.1016\/j.compbiolchem.2026.109012_bib65","doi-asserted-by":"crossref","DOI":"10.31083\/j.fbl2807151","article-title":"Silico insight to identify potential inhibitors of BUB1B from mushroom bioactive compounds to prevent breast cancer metastasis","volume":"28","author":"Mishra","year":"2023","journal-title":"Front. Biosci. Landmark"},{"key":"10.1016\/j.compbiolchem.2026.109012_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.135762","article-title":"Bioactivity studies and Insilico studies of the isolated compound from ancient plant Vitex negundo against breast cancer","volume":"1288","author":"Mohammad","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.compbiolchem.2026.109012_bib67","doi-asserted-by":"crossref","unstructured":"P.K. Mou, E.J. Yang, C. Shi, G. Ren, S. Tao, and J.S. Shim, \u201cAurora kinase A, a synthetic lethal target for precision cancer medicine,\u201d May 01, 2021, Springer Nature. doi: 10.1038\/s12276-021-00635-6.","DOI":"10.1038\/s12276-021-00635-6"},{"key":"10.1016\/j.compbiolchem.2026.109012_bib68","article-title":"Unveiling potential targeted therapeutic opportunities for co-overexpressed targeting protein for Xklp2 and Aurora-A kinase in lung adenocarcinoma","author":"Mukherjee","year":"2023","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.compbiolchem.2026.109012_bib69","doi-asserted-by":"crossref","unstructured":"V. Palve, Y. Liao, L.L. Remsing Rix, and U. Rix, \u201cTurning liabilities into opportunities: Off-target based drug repurposing in cancer,\u201d Jan. 01, 2021, Academic Press. doi: 10.1016\/j.semcancer.2020.02.003.","DOI":"10.1016\/j.semcancer.2020.02.003"},{"key":"10.1016\/j.compbiolchem.2026.109012_bib70","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.2147\/OTT.S136491","article-title":"Targeted TPX2 increases chromosome missegregation and suppresses tumor cell growth in human prostate cancer","volume":"10","author":"Pan","year":"2017","journal-title":"Onco. Targets Ther."},{"issue":"21","key":"10.1016\/j.compbiolchem.2026.109012_bib71","doi-asserted-by":"crossref","first-page":"11252","DOI":"10.1074\/jbc.M115.702142","article-title":"Functional and structural characterization of Bub3\u2022BubR1 interactions required for spindle assembly checkpoint signaling in human cells","volume":"291","author":"Prinz","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.compbiolchem.2026.109012_bib72","doi-asserted-by":"crossref","unstructured":"S. Pushpakom et al., \u201cDrug repurposing: Progress, challenges and recommendations,\u201d Dec. 28, 2018, Nature Publishing Group. doi: 10.1038\/nrd.2018.168.","DOI":"10.1038\/nrd.2018.168"},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109012_bib73","doi-asserted-by":"crossref","DOI":"10.1186\/s43088-021-00149-0","article-title":"silico screening and molecular docking study of compounds from Pedalium murex L. with Vasopressin2 receptor target for autosomal dominant polycystic kidney disease","volume":"10","author":"Ram","year":"2021","journal-title":"Beni. Suef. Univ. J. Basic Appl. Sci."},{"issue":"35","key":"10.1016\/j.compbiolchem.2026.109012_bib74","doi-asserted-by":"crossref","first-page":"33422","DOI":"10.1074\/jbc.M303173200","article-title":"Identification and characterization of a cell cycle and apoptosis regulatory protein-1 as a novel mediator of apoptosis signaling by retinoid CD437","volume":"278","author":"Rishi","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109012_bib75","doi-asserted-by":"crossref","first-page":"27","DOI":"10.31557\/apjcb.2025.10.1.27-35","article-title":"Identification and functional characterization of upregulated hub genes in adenocarcinoma across multiple organ sites","volume":"10","author":"Romero","year":"2025","journal-title":"Asian Pac. J. Cancer Biol."},{"key":"10.1016\/j.compbiolchem.2026.109012_bib76","article-title":"Small molecules, big targets: drug discovery faces the protein-protein interaction challenge","author":"Scott","year":"2016","journal-title":"Nat. Publ. Group"},{"issue":"11","key":"10.1016\/j.compbiolchem.2026.109012_bib77","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"issue":"7","key":"10.1016\/j.compbiolchem.2026.109012_bib78","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/07482337231175970","article-title":"Identification of critical genes associated with lead exposure based on in silico analysis","volume":"39","author":"Sharma","year":"2023","journal-title":"Toxicol. Ind. Health"},{"issue":"2","key":"10.1016\/j.compbiolchem.2026.109012_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0296511","article-title":"Machine learning and bioinformatic analyses link the cell surface receptor transcript levels to the drug response of breast cancer cells and drug off-target effects","volume":"19","author":"Sinkala","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.compbiolchem.2026.109012_bib80","doi-asserted-by":"crossref","unstructured":"E. Song and R.D. Chow, \u201cMutations in IFN-\u03b3 signaling genes sensitize tumors to immune checkpoint blockade,\u201d Apr. 10, 2023, Cell Press. doi: 10.1016\/j.ccell.2023.02.013.","DOI":"10.1016\/j.ccell.2023.02.013"},{"issue":"17","key":"10.1016\/j.compbiolchem.2026.109012_bib81","doi-asserted-by":"crossref","first-page":"15521","DOI":"10.1021\/acs.jmedchem.4c01165","article-title":"Selective Aurora A-TPX2 interaction inhibitors have in vivo efficacy as targeted antimitotic agents","volume":"67","author":"Stockwell","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2026.109012_bib82","doi-asserted-by":"crossref","unstructured":"Y.S. Sun et al., \u201cRisk factors and preventions of breast cancer,\u201d 2017, Ivyspring International Publisher. doi: 10.7150\/ijbs.21635.","DOI":"10.7150\/ijbs.21635"},{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109012_bib83","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1 D","key":"10.1016\/j.compbiolchem.2026.109012_bib84","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"10.1016\/j.compbiolchem.2026.109012_bib85","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.compbiolchem.2026.109012_bib86","article-title":"Exploring the anti-cancer potential of daidzin in breast cancer: Integrated bioinformatics and computational insights on oncogene inhibition","volume":"119","author":"Uddin","year":"2025","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.compbiolchem.2026.109012_bib87","doi-asserted-by":"crossref","unstructured":"S. Vajda, D. Beglov, A.E. Wakefield, M. Egbert, and A. Whitty, \u201cCryptic binding sites on proteins: definition, detection, and druggability,\u201d Jun. 01, 2018, Elsevier Ltd. doi: 10.1016\/j.cbpa.2018.05.003.","DOI":"10.1016\/j.cbpa.2018.05.003"},{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109012_bib88","doi-asserted-by":"crossref","DOI":"10.5599\/admet.2772","article-title":"Leveraging machine learning models in evaluating ADMET properties for drug discovery and development","volume":"13","author":"Venkataraman","year":"2025","journal-title":"ADMET DMPK"},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109012_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics13010067","article-title":"A comparison of techniques for class imbalance in deep learning classification of breast cancer","volume":"13","author":"Walsh","year":"2023","journal-title":"Diagnostics"},{"issue":"11","key":"10.1016\/j.compbiolchem.2026.109012_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/genes16111389","article-title":"Integrated bioinformatics and machine learning for ascertainment and validation of biomarkers for screening breast disease","volume":"16","author":"Wang","year":"2025","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.compbiolchem.2026.109012_bib91","article-title":"Integration of multi-omics data reveals a novel hybrid breast cancer subtype and its biomarkers","volume":"13","author":"Wang","year":"2023","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.compbiolchem.2026.109012_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jpm11020061","article-title":"Breast cancer type classification using machine learning","volume":"11","author":"Wu","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.compbiolchem.2026.109012_bib93","article-title":"Prioritizing oral bioavailability in drug development strategies","author":"Xie","year":"2025","journal-title":"Taylor Fr. Ltd"},{"issue":"4","key":"10.1016\/j.compbiolchem.2026.109012_bib94","article-title":"Co-expression network and survival analysis of breast cancer inflammation and immune system hallmark genes","volume":"113","author":"Yakushi","year":"2024","journal-title":"Comput. Biol. Chem."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109012_bib95","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-94084-0","article-title":"Cohesive data analysis for the identification of prognostic hub genes and significant pathways associated with HER2 + and TN breast cancer types","volume":"15","author":"Zakir","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiolchem.2026.109012_bib96","doi-asserted-by":"crossref","unstructured":"Z. Zhang et al., \u201cOvercoming cancer therapeutic bottleneck by drug repurposing,\u201d Dec. 01, 2020, Springer Nature. doi: 10.1038\/s41392-020-00213-8.","DOI":"10.1038\/s41392-020-00213-8"},{"issue":"W1","key":"10.1016\/j.compbiolchem.2026.109012_bib97","doi-asserted-by":"crossref","first-page":"W234","DOI":"10.1093\/nar\/gkz240","article-title":"NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis","volume":"47","author":"Zhou","year":"2019","journal-title":"Nucleic Acids Res"}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927126001374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927126001374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T07:40:53Z","timestamp":1778053253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927126001374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":97,"alternative-id":["S1476927126001374"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2026.109012","relation":{},"ISSN":["1476-9271"],"issn-type":[{"value":"1476-9271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico discovery of selective TPX2 and BUB1B inhibitors as novel antimitotic agents in breast cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2026.109012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109012"}}